The U.S. Food and Drug Administration has issued a public health advisory concerning the correct use of Spiriva and Foradil capsules.
The FDA said it learned many patients are swallowing the capsules, rather than placing them in inhalation devices, as they are intended to be administered.
The medications in the capsules are specifically designed to be inhaled through the Spiriva HandiHaler and Foradil Aerolizer inhalation devices to improve breathing in patients with asthma, and in individuals affected by chronic obstructive lung disease, including chronic bronchitis and emphysema.
Although few patients experience any side effects from swallowing the capsules, the FDA said neither medication will treat a patient's breathing problems if the capsules are swallowed rather than inhaled.
The FDA advised healthcare professionals to discuss with patients how to correctly use the Spiriva HandiHaler or Foradil Aerolizer and will consider, if needed, revising the medications' labeling.
Copyright 2008 by United Press International
Related stories:
Herbal Science-brand supplements recalled
The U.S. Food and Drug Administration announced the recall of 12 Herbal Science-brand dietary supplements because they might present a health hazard.
FDA warns about dietary supplements
The U.S. Food and Drug Administration has advised consumers not to use "Blue Steel" or "Hero" dietary supplements.
Aspire36, Aspire Lite supplements recalled
The U.S. Food and Drug Administration announced the nationwide recall of Aspire36 and Aspire Lite dietary supplements due to a safety issue.
New technique to 'see' and protect transplants successful in diabetic animal model
Researchers at Johns Hopkins have found a way to overcome a major stumbling block to developing successful insulin-cell transplants for people with type I diabetes.
Shark cartilage capsules are recalled
The U.S. Food and Drug Administration has announced the recall of shark cartilage capsules because of possible contamination with salmonella.
FDA approves skin cancer drug
The U.S. Food and Drug Administration approved a new drug to treat a rare, slow-growing skin cancer.
Olive leaf extract can help tackle high blood pressure and cholesterol
Taking 1000mg of a specific olive leaf extract (EFLAŽ943) can lower cholesterol and lower blood pressure in patients with mild hypertension (high blood pressure). These findings came from a 'Twins' trial, in which different treatments were given to identical twins. By doing this, researchers could increase the power of their data by eliminating some of the uncertainties caused by genetic variations between individual people.
Alzheimer's disease patients show improvement in trial of new drug
A new drug has been shown to improve the brain function of people with early stage Alzheimer's disease and reduce a key protein associated with the disease in the spinal fluid, in a small study published today in the journal
Lancet Neurology and presented at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease.